Crossref
Statins and Fenofibrate in Diabetic Retinopathy — A Narrative Review of Recent Clinical Evidence (2020–2025)
Clinical Diabetology · 25.05.2026
DOI: 10.5603/cd.109887 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Diabetology, online erschienen am 25.05.2026. Verfasst von Weronika Dmoch und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Dmoch, W., Sawicka, J., Żelichowska, N., Kępczyńska, Z., Maciejewicz, P., & Kęcik, D. (2026). Statins and Fenofibrate in Diabetic Retinopathy — A Narrative Review of Recent Clinical Evidence (2020–2025). Clinical Diabetology. https://doi.org/10.5603/cd.109887
Vancouver
Dmoch W, Sawicka J, Żelichowska N, Kępczyńska Z, Maciejewicz P, Kęcik D. Statins and Fenofibrate in Diabetic Retinopathy — A Narrative Review of Recent Clinical Evidence (2020–2025). Clinical Diabetology. 2026. doi:10.5603/cd.109887
BibTeX
@article{Dmoch2026,
author = {Dmoch, Weronika and Sawicka, Julia and Żelichowska, Natalia and Kępczyńska, Zuzanna and Maciejewicz, Piotr and Kęcik, Dariusz},
title = {Statins and Fenofibrate in Diabetic Retinopathy — A Narrative Review of Recent Clinical Evidence (2020–2025)},
journal = {Clinical Diabetology},
year = {2026},
doi = {10.5603/cd.109887}
}
EUVIMED